Strategic Blueprint’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Buy
13,246
+331
+3% +$38.7K 0.09% 230
2026
Q1
$1.55M Buy
12,915
+1,271
+11% +$147K 0.09% 217
2025
Q4
$1.23M Buy
11,644
+2,869
+33% +$269K 0.07% 247
2025
Q3
$737K Buy
8,775
+302
+4% +$24.9K 0.03% 395
2025
Q2
$671K Sell
8,473
-1,108
-12% -$88.1K 0.03% 375
2025
Q1
$860K Sell
9,581
-28,192
-75% -$2.63M 0.05% 313
2024
Q4
$3.76M Sell
37,773
-14,160
-27% -$1.46M 0.22% 104
2024
Q3
$5.9M Buy
51,933
+3,840
+8% +$456K 0.37% 67
2024
Q2
$5.95M Sell
48,093
-274
-0.6% -$35.3K 0.4% 58
2024
Q1
$6.38M Sell
48,367
-2,891
-6% -$356K 0.45% 55
2023
Q4
$5.59M Buy
51,258
+4,759
+10% +$494K 0.46% 52
2023
Q3
$4.79M Buy
46,499
+3,236
+7% +$349K 0.44% 53
2023
Q2
$4.99M Buy
43,263
+8,361
+24% +$949K 0.48% 50
2023
Q1
$3.71M Buy
34,902
+1,231
+4% +$133K 0.38% 58
2022
Q4
$3.74M Sell
33,671
-1,473
-4% -$151K 0.43% 53
2022
Q3
$3.03M Buy
35,144
+28,239
+409% +$2.52M 0.36% 68
2022
Q2
$630K Buy
6,905
+1,095
+19% +$97.1K 0.08% 241
2022
Q1
$477K Buy
5,810
+68
+1% +$5.36K 0.06% 290
2021
Q4
$440K Buy
5,742
+2,810
+96% +$224K 0.06% 286
2021
Q3
$220K Buy
2,932
+1,324
+82% +$101K 0.03% 375
2021
Q2
$125K Buy
+1,608
New +$120K 0.02% 461
2020
Q4
Sell
-25,059
Closed -$1.98M 255
2020
Q3
$1.98M Buy
+25,059
New +$1.96M 0.61% 45
2019
Q4
Sell
-188
Closed -$15K 300
2019
Q3
$15K Buy
+188
New +$15.1K 0.01% 259

Other funds holding MRK

Strategic Blueprint's MRK Position: Q2 2026 in Review

Strategic Blueprint increased its Merck (MRK) stake by 2.6% in Q2 2026, buying an estimated $38.7K and bringing the position to 13,246 shares worth $1.7M. The position accounts for 0.09% of the portfolio, ranked #230.

Strategic Blueprint first reported a position in MRK in Q3 2019 and has held it in 23 quarters since. The position peaked at $6.38M in Q1 2024. 1,770 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Strategic Blueprint held 13,246 shares of Merck worth $1.7M as of Q2 2026.
  • Strategic Blueprint bought 331 Merck shares in Q2 2026, an estimated $38.7K.
  • Merck made up 0.09% of Strategic Blueprint's portfolio in Q2 2026, its #230 holding.
  • Strategic Blueprint first reported a position in Merck in Q3 2019 and has held it in 23 quarters since.
  • Strategic Blueprint's Merck position peaked at $6.38M in Q1 2024.
  • 1,770 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.